Lessee, Operating Lease, Liability, to be Paid, Year Two of Oncternal Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Oncternal Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
  • Oncternal Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2024 was $150,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Oncternal Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $150,000 $0 0% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $150,000 $0 0% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $150,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $150,000 31 Dec 2023 10-K 07 Mar 2024 2023 FY
Q3 2023 $150,000 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $150,000 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q2 2020 $41,000 -$125,000 -75% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $41,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $41,000 31 Dec 2019 10-K 16 Mar 2020 2019 FY
Q3 2019 $166,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $166,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.